Loading…

Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy

To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-...

Full description

Saved in:
Bibliographic Details
Published in:Korean journal of ophthalmology 2017, 31(3), , pp.217-229
Main Authors: Ramezani, Alireza, Ahmadieh, Hamid, Rozegar, Amin, Soheilian, Masoud, Entezari, Morteza, Moradian, Siamak, Dehghan, Mohammad H, Nikkhah, Homayoun, Yaseri, Mehdi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93
cites cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93
container_end_page 229
container_issue 3
container_start_page 217
container_title Korean journal of ophthalmology
container_volume 31
creator Ramezani, Alireza
Ahmadieh, Hamid
Rozegar, Amin
Soheilian, Masoud
Entezari, Morteza
Moradian, Siamak
Dehghan, Mohammad H
Nikkhah, Homayoun
Yaseri, Mehdi
description To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with >3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate. At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200. Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.
doi_str_mv 10.3341/kjo.2016.0018
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_1379563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1901766743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</originalsourceid><addsrcrecordid>eNpVkUtrGzEURkVpady0y26Llu1inCtpRqPZFEz6MgQckrRbodGjkT0judI44H9f2U5DikB38R19V3AQek9gzlhNLjbrOKdA-ByAiBdoRqGjVccEfYlmBAipRFfTM_Qm5zUAJwza1-iMiobV5cyQuk7WeD3FlLEKBq92k46jzTg6_MtPyZZo3B-jWz94HYPFKz_gZViXyMeAfcAL86CCtgZ_8aq3k9f4ptwhbtV0v3-LXjk1ZPvucZ6jn9--3l3-qK5W35eXi6tKU85FxXoG2vBWaQq2BurANAANbYXuwRGigauup1r1QgjdGnBccXCmd8ZRqzt2jj6dekNycqO9jMof5-8oN0kubu6WkrC2azgr7OcTu931ozXahimpQW6TH1XaH1_-nwR_X3oeZFPzrqNNKfj4WJDin53Nkxx91nYYVLBxlyXpgLSct_VhV3VCdYo5J-ue1hCQB4WyKJQHhfKgsPAfnv_tif7njP0FY6aZAQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901766743</pqid></control><display><type>article</type><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><source>PubMed Central (Open Access)</source><creator>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</creator><creatorcontrib>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</creatorcontrib><description>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with &gt;3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate. At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200. Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</description><identifier>ISSN: 1011-8942</identifier><identifier>EISSN: 2092-9382</identifier><identifier>DOI: 10.3341/kjo.2016.0018</identifier><identifier>PMID: 28534343</identifier><language>eng</language><publisher>Korea (South): The Korean Ophthalmological Society</publisher><subject>Adult ; Aged ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - surgery ; Endotamponade - methods ; Female ; Follow-Up Studies ; Humans ; Injections ; Male ; Middle Aged ; Original ; Postoperative Complications ; Retrospective Studies ; Silicone Oils - administration &amp; dosage ; Time Factors ; Treatment Outcome ; Visual Acuity ; Vitrectomy - methods ; Young Adult ; 안과학</subject><ispartof>Korean Journal of Ophthalmology, 2017, 31(3), , pp.217-229</ispartof><rights>2017 The Korean Ophthalmological Society</rights><rights>2017 The Korean Ophthalmological Society 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</citedby><cites>FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469925/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469925/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28534343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227613$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramezani, Alireza</creatorcontrib><creatorcontrib>Ahmadieh, Hamid</creatorcontrib><creatorcontrib>Rozegar, Amin</creatorcontrib><creatorcontrib>Soheilian, Masoud</creatorcontrib><creatorcontrib>Entezari, Morteza</creatorcontrib><creatorcontrib>Moradian, Siamak</creatorcontrib><creatorcontrib>Dehghan, Mohammad H</creatorcontrib><creatorcontrib>Nikkhah, Homayoun</creatorcontrib><creatorcontrib>Yaseri, Mehdi</creatorcontrib><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><title>Korean journal of ophthalmology</title><addtitle>Korean J Ophthalmol</addtitle><description>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with &gt;3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate. At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200. Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</description><subject>Adult</subject><subject>Aged</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - surgery</subject><subject>Endotamponade - methods</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Injections</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Postoperative Complications</subject><subject>Retrospective Studies</subject><subject>Silicone Oils - administration &amp; dosage</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Visual Acuity</subject><subject>Vitrectomy - methods</subject><subject>Young Adult</subject><subject>안과학</subject><issn>1011-8942</issn><issn>2092-9382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkUtrGzEURkVpady0y26Llu1inCtpRqPZFEz6MgQckrRbodGjkT0judI44H9f2U5DikB38R19V3AQek9gzlhNLjbrOKdA-ByAiBdoRqGjVccEfYlmBAipRFfTM_Qm5zUAJwza1-iMiobV5cyQuk7WeD3FlLEKBq92k46jzTg6_MtPyZZo3B-jWz94HYPFKz_gZViXyMeAfcAL86CCtgZ_8aq3k9f4ptwhbtV0v3-LXjk1ZPvucZ6jn9--3l3-qK5W35eXi6tKU85FxXoG2vBWaQq2BurANAANbYXuwRGigauup1r1QgjdGnBccXCmd8ZRqzt2jj6dekNycqO9jMof5-8oN0kubu6WkrC2azgr7OcTu931ozXahimpQW6TH1XaH1_-nwR_X3oeZFPzrqNNKfj4WJDin53Nkxx91nYYVLBxlyXpgLSct_VhV3VCdYo5J-ue1hCQB4WyKJQHhfKgsPAfnv_tif7njP0FY6aZAQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Ramezani, Alireza</creator><creator>Ahmadieh, Hamid</creator><creator>Rozegar, Amin</creator><creator>Soheilian, Masoud</creator><creator>Entezari, Morteza</creator><creator>Moradian, Siamak</creator><creator>Dehghan, Mohammad H</creator><creator>Nikkhah, Homayoun</creator><creator>Yaseri, Mehdi</creator><general>The Korean Ophthalmological Society</general><general>대한안과학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>201706</creationdate><title>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</title><author>Ramezani, Alireza ; Ahmadieh, Hamid ; Rozegar, Amin ; Soheilian, Masoud ; Entezari, Morteza ; Moradian, Siamak ; Dehghan, Mohammad H ; Nikkhah, Homayoun ; Yaseri, Mehdi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - surgery</topic><topic>Endotamponade - methods</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Injections</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Postoperative Complications</topic><topic>Retrospective Studies</topic><topic>Silicone Oils - administration &amp; dosage</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Visual Acuity</topic><topic>Vitrectomy - methods</topic><topic>Young Adult</topic><topic>안과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramezani, Alireza</creatorcontrib><creatorcontrib>Ahmadieh, Hamid</creatorcontrib><creatorcontrib>Rozegar, Amin</creatorcontrib><creatorcontrib>Soheilian, Masoud</creatorcontrib><creatorcontrib>Entezari, Morteza</creatorcontrib><creatorcontrib>Moradian, Siamak</creatorcontrib><creatorcontrib>Dehghan, Mohammad H</creatorcontrib><creatorcontrib>Nikkhah, Homayoun</creatorcontrib><creatorcontrib>Yaseri, Mehdi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Korean journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramezani, Alireza</au><au>Ahmadieh, Hamid</au><au>Rozegar, Amin</au><au>Soheilian, Masoud</au><au>Entezari, Morteza</au><au>Moradian, Siamak</au><au>Dehghan, Mohammad H</au><au>Nikkhah, Homayoun</au><au>Yaseri, Mehdi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy</atitle><jtitle>Korean journal of ophthalmology</jtitle><addtitle>Korean J Ophthalmol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>31</volume><issue>3</issue><spage>217</spage><epage>229</epage><pages>217-229</pages><issn>1011-8942</issn><eissn>2092-9382</eissn><abstract>To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil (SO) injection outcomes in proliferative diabetic retinopathy (PDR). This retrospective study included 236 eyes with PDR that were undergoing vitrectomy and SO injection with &gt;3-month follow-up. The primary outcomes were final best-corrected visual acuity (BCVA) and retinal attachment rate. At the final visit (mean, 88 ± 58 weeks), complete, partial, and no retinal attachment were observed in 86.9%, 10.6%, and 2.5% of patients, respectively. A total of 155 eyes had experienced SO removal, while 81 had SO in place. The mean initial BCVA was 1.9 ± 0.7 logarithm of the minimum angle of resolution (logMAR) and significantly improved to 1.7 ± 0.8 logMAR (p = 0.001). Initial macular detachment (adjusted odds ratio [AOR], 0.25), development of iatrogenic break (AOR, 0.25), and use of heavy SO (AOR, 0.13) were independently associated with a lower risk of final retinal attachment, and SO removal was associated with a higher incidence (AOR, 7.55). Better baseline BCVA was associated with a higher risk of final BCVA ≥20 / 200. Despite an encouraging outcome based on anatomical data in advanced PDR treated with vitrectomy and SO, the functional prognosis was not satisfying for patients. Eyes with better vision at baseline had a more favorable prognosis, whereas eyes with initial macular detachment, intraoperative iatrogenic break, or heavy SO showed more unfavorable outcomes. In selected cases, extending the time of SO use did not worsen the prognosis.</abstract><cop>Korea (South)</cop><pub>The Korean Ophthalmological Society</pub><pmid>28534343</pmid><doi>10.3341/kjo.2016.0018</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1011-8942
ispartof Korean Journal of Ophthalmology, 2017, 31(3), , pp.217-229
issn 1011-8942
2092-9382
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_1379563
source PubMed Central (Open Access)
subjects Adult
Aged
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - surgery
Endotamponade - methods
Female
Follow-Up Studies
Humans
Injections
Male
Middle Aged
Original
Postoperative Complications
Retrospective Studies
Silicone Oils - administration & dosage
Time Factors
Treatment Outcome
Visual Acuity
Vitrectomy - methods
Young Adult
안과학
title Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A39%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20and%20Outcomes%20of%20Vitrectomy%20and%20Silicone%20Oil%20Injection%20in%20Advanced%20Diabetic%20Retinopathy&rft.jtitle=Korean%20journal%20of%20ophthalmology&rft.au=Ramezani,%20Alireza&rft.date=2017-06&rft.volume=31&rft.issue=3&rft.spage=217&rft.epage=229&rft.pages=217-229&rft.issn=1011-8942&rft.eissn=2092-9382&rft_id=info:doi/10.3341/kjo.2016.0018&rft_dat=%3Cproquest_nrf_k%3E1901766743%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2668-3b30cd67ac20e402f0d5005278cb0f11c06a9b2cab888c7d0f6a60fdbfdf2ec93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1901766743&rft_id=info:pmid/28534343&rfr_iscdi=true